RxDoctor Payments Data

Arthur Lauretano, MD

Otolaryngology · Chelmsford, MANPI 1104814375

Payments from drug & device makers

What this record shows

The money is spread across several categories — food and beverage (44.8%), consulting fees and travel and lodging — rather than concentrated in one kind of arrangement. 7 manufacturers reported payments, led by Inspire Medical Systems, Inc. at 56.9% of the total. 2025 is the largest year on record at $1,805, 7.0 times the $256 reported in 2019.

$4,443in general payments, 2019–2025

Across 43 payments — averaging $103.33 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Inspire Medical Systems, Inc.$3K
  • Microline Surgical Inc$2K
  • Intuitive Surgical$131
  • Baxter Healthcare$125
  • Regeneron Healthcare Solutions, Inc.$23
  • Stryker$20
  • plus $14 from 1 others

What the payments were for

  • Consulting fees$1,60036%
  • Travel & lodging$85219%
  • Food & beverage$1,99245%

General payments by program year

19
21
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Inspire Medical Systems, Inc.35$2,530
Microline Surgical Inc2$1,600
Intuitive Surgical2$131
Baxter Healthcare1$125
Regeneron Healthcare Solutions, Inc.1$23
Stryker1$20
Sanofi1$14

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$4,443 in reported general payments places this provider in the 85th percentile of 298 otolaryngology providers in Massachusetts.

See all otolaryngology providers in Massachusetts

Medicare billing

Part B allowed, 2024
$239,740
Medicare patients
734
Services billed
1,900

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Ciprofloxacin-DexamethasoneCiprofloxacin Hcl/Dexameth26$2,874
Ofloxacin49$2,314
Azelastine Hcl52$2,161
Pilocarpine Hcl13$1,079
Fluocinolone Acetonide Oil22$931
Ipratropium Bromide26$795
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav70$685
Fluticasone Propionate49$599
Albuterol Sulfate HfaAlbuterol Sulfate24$536
CefuroximeCefuroxime Axetil18$484
Oxycodone Hcl51$431
Clindamycin Hcl23$362
Mupirocin27$347
Methylprednisolone55$322
Ondansetron OdtOndansetron37$235

Paid to pharmacies, not to this prescriber.

Other otolaryngology in Chelmsford

See the full list for Massachusetts

Where these figures come from

Is this you, or does something look wrong? →